162 related articles for article (PubMed ID: 20921826)
1. Influence of histological subtype on survival after combined therapy of surgery and radiation in WHO grade 3 glioma.
Shirai K; Suzuki Y; Okamoto M; Wakatsuki M; Noda SE; Takahashi T; Ishiuchi S; Hasegawa M; Nakazato Y; Nakano T
J Radiat Res; 2010; 51(5):589-94. PubMed ID: 20921826
[TBL] [Abstract][Full Text] [Related]
2. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
3. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
5. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
[TBL] [Abstract][Full Text] [Related]
7. [A molecular classification system for anaplastic glioma].
Jiang HH; Ren XH; Zhang Z; Lin S
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1104-9. PubMed ID: 24499721
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas.
Nagy M; Schulz-Ertner D; Bischof M; Welzel T; Hof H; Debus J; Combs SE
Tumori; 2009; 95(3):317-24. PubMed ID: 19688970
[TBL] [Abstract][Full Text] [Related]
9. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
[TBL] [Abstract][Full Text] [Related]
10. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.
Nunna RS; Khalid S; Ryoo JS; Sethi A; Byrne RW; Mehta AI
Clin Transl Oncol; 2021 Mar; 23(3):628-637. PubMed ID: 32691365
[TBL] [Abstract][Full Text] [Related]
12. Adult low-grade glioma: 19-year experience at a single institution.
Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
[TBL] [Abstract][Full Text] [Related]
13. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative radiotherapy of supratentorial anaplastic glioma].
Wendt TG; Bacherler B; Baumer K; Rohloff R; Willich N
Strahlenther Onkol; 1986 Jun; 162(6):347-53. PubMed ID: 3738736
[TBL] [Abstract][Full Text] [Related]
16. Low-grade gliomas in children: tumor volume response to radiation.
Fisher BJ; Bauman GS; Leighton CE; Stitt L; Cairncross JG; Macdonald DR
J Neurosurg; 1998 Jun; 88(6):969-74. PubMed ID: 9609290
[TBL] [Abstract][Full Text] [Related]
17. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
20. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
